Glucocorticoid-induced modulation of cytokine secretion from normal and leukemic human myelomonocytic cells.
Since glucocorticoid effects on inflammatory processes may be mediated via modulation of cytokine release, different types of myelomonocytic cells were stimulated in vitro with lipopolysaccharide (50 ng/ml) or phorbol myristate acetate (25 ng/ml) plus the ionophore A23187, 2 x 10(-7) M, and release of interleukin (IL)-1 beta, IL-8 and tumor necrosis factor (TNF)-alpha was measured after 24 h by ELISA. Peripheral blood mononuclear cells from two allergic and two normal human donors released similarly large quantities of IL-8 and lower amounts of IL-1 beta and TNF-alpha. This also held for myelomonocytic cell lines, with THP-1 cells being most active, followed by U-937 and HL-60 cells. All potent glucocorticoids studied caused a dose-dependent inhibition of cytokine release from donor cells, being most marked for IL-1 beta and lowest for IL-8. Inhibition of cytokine release was also noted with U-937 cells, with clear differences in potency between the glucocorticoids, whereas release was enhanced in all experiments with THP-1 cells. These results were confirmed with Northern blot analysis. Modulating effects of glucocorticoids on cytokine release are thus complex, and are particularly dependent on the cell type studied.
Welker
P
P
Department of Dermatology, Virchow Clinics of Humboldt University, Berlin, Germany.
Lippert
U
U
Nürnberg
W
W
Krüger-Krasagakes
S
S
Möller
A
A
Czarnetzki
B M
BM
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D016207:Cytokines / Q000097:blood / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D005938:Glucocorticoids / Q000494:pharmacology*; D006801:Humans; D015479:Leukemia, Myelomonocytic, Acute / Q000378:metabolism* / Q000473:pathology*; D015477:Leukemia, Myelomonocytic, Chronic / Q000378:metabolism* / Q000473:pathology*; D007963:Leukocytes, Mononuclear / Q000378:metabolism; D008070:Lipopolysaccharides / Q000494:pharmacology; D008775:Methylprednisolone / Q000031:analogs & derivatives / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects
D000893:Anti-Inflammatory Agents; D016207:Cytokines; D005938:Glucocorticoids; D008070:Lipopolysaccharides; C078007:methylprednisolone aceponate; D008775:Methylprednisolone